Trade Summary

5 days ago, Valamehr Bahram, serving as Pres, CEO at Fate Therapeutics Inc (FATE), sold 28,946 shares at $1.88 per share, for a total transaction value of $54,482.00. Following this transaction, Valamehr Bahram now holds 635,762 shares of FATE.

This sale represents a 4.00% decrease in Valamehr Bahram's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 20, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 21, 2026 at 4:01 PM ET, 1 day after the trade was made.

Fate Therapeutics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.